Betterlife Pharma Inc. (TSE:BETR) has released an update.
BetterLife Pharma Inc. is set to showcase its innovative treatments for mental health disorders at the prestigious Bloom Burton & Co. Healthcare Investor Conference in Toronto. The event is a key platform for investors worldwide to discover leading-edge companies in the healthcare sector and engage in one-on-one meetings with executives. In addition, the company recently resolved a legal claim by issuing shares and continues to focus on developing its core compounds for neuropsychiatric and neurological disorders.
For further insights into TSE:BETR stock, check out TipRanks’ Stock Analysis page.
